etoposide has been researched along with Genito-urinary Cancer in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 4 (33.33) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buizen, L; Friedlander, M; Gebski, V; Grimison, P; Gurney, H; Kichenadasse, G; Lawrence, N; Lewis, C; Martin, A; Rosenthal, M; Singhal, N; Stockler, M; Thomson, D; Toner, G; Vasey, P; Wong, N; Wong, S; Yeung, A | 1 |
He, J; Song, Y; Wang, JW; Wang, LH; Wu, LY | 1 |
Billmire, D; Colombani, P; Cullen, J; Cushing, B; Davis, M; Giller, R; Hawkins, E; Lauer, S; London, W; Rescorla, F; Vinocur, C | 1 |
Csoka, K; Larsson, R; Liliemark, J; Nygren, P | 1 |
Arndt, CA; Miser, JS; Moertel, CL; Nascimento, AG; Neglia, JP; Schomberg, PJ; Schroeder, G; Sencer, SF; Silberman, TL; Tillisch, JK | 1 |
Alexander, RB | 1 |
Kondo, I; Moriyama, M; Murai, T | 1 |
Kotake, T; Kuroda, M; Miki, T | 1 |
Suzuki, K | 1 |
Akagi, T; Johsen, T; Matsumura, Y; Nasu, Y; Obama, T; Ohmori, H; Suyama, B; Tanahashi, T; Tsushima, T; Yoshimoto, J | 1 |
Aota, Y; Kinjo, T; Mitsuya, H; Murase, T; Shimoji, T | 1 |
1 review(s) available for etoposide and Genito-urinary Cancer
Article | Year |
---|---|
Tumor necrosis factor and chemotherapeutic drugs targeted at DNA topoisomerase II for the treatment of genitourinary malignancies.
Topics: Animals; DNA Topoisomerases, Type II; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Mice; Tumor Necrosis Factor-alpha; Urogenital Neoplasms | 1992 |
1 trial(s) available for etoposide and Genito-urinary Cancer
Article | Year |
---|---|
The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Infant; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Penile Neoplasms; Survival Rate; Treatment Outcome; Urogenital Neoplasms; Uterine Neoplasms; Vaginal Neoplasms | 2003 |
10 other study(ies) available for etoposide and Genito-urinary Cancer
Article | Year |
---|---|
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Male; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; New Zealand; Prostatic Neoplasms; Time Factors; Treatment Outcome; Urogenital Neoplasms | 2016 |
[Treatment and prognosis of extrapulmonary small cell carcinoma of 243 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Etoposide; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy, High-Energy; Survival Rate; Urogenital Neoplasms; Young Adult | 2010 |
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms | 1995 |
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Meningeal Neoplasms; Pilot Projects; Rhabdomyosarcoma; Risk Factors; Sarcoma; Urogenital Neoplasms; Vincristine | 1998 |
[CEM chemotherapy (cisplatin, etoposide, methotrexate) for advanced urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Urogenital Neoplasms | 1990 |
[Clinical evaluation of chemotherapy in urologic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Penile Neoplasms; Prognosis; Remission Induction; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine | 1989 |
[Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Topics: Adult; Aged; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1986 |
[Treatment of urogenital cancers with oral VP-16].
Topics: Administration, Oral; Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Kinetics; Male; Middle Aged; Urogenital Neoplasms | 1986 |
[Effect of etoposide for urogenital tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pancreatic Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Rhabdomyosarcoma; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1985 |
[Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Topics: Administration, Oral; Alopecia; Anorexia; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kidney Neoplasms; Male; Nausea; Podophyllotoxin; Prostatic Neoplasms; Testicular Neoplasms; Urogenital Neoplasms | 1985 |